Filing Details
- Accession Number:
- 0001209191-23-004345
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-23 08:27:05
- Reporting Period:
- 2023-01-18
- Accepted Time:
- 2023-01-23 08:27:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818794 | Dyne Therapeutics Inc. | DYN | Pharmaceutical Preparations (2834) | 364883909 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1824673 | Jonathan Mcneill | C/O Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham MA 02451 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-18 | 10,000 | $0.73 | 77,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-18 | 10,000 | $14.03 | 67,600 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-01-18 | 10,000 | $0.00 | 10,000 | $0.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 68,528 | 2029-02-25 | No | 4 | M | Direct |
Footnotes
- This is an inadvertent late filing due to an administrative error.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $14.00 to $14.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- The option was granted on February 26, 2019. The shares underlying the option vest over four years, with 25% of the shares vesting on February 1, 2020 and the remaining shares vesting in equal quarterly installments thereafter.
Billionaire Hedge Funds
